Akari Therapeutics (AKTX)
NASDAQ: AKTX
· Real-Time Price · USD
1.00
0.03 (3.08%)
At close: Aug 15, 2025, 3:58 PM
1.00
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
Akari Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 |
PEG Ratio | -0.00 | -0.00 | 0.00 | n/a | -0.00 | n/a | n/a | 0.00 | -0.00 | n/a | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.00 | 0.00 | -0.01 | -0.01 | -0.00 | -0.07 | -0.09 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.00 | 0.01 | 0.01 | 0.04 | 0.03 |
P/FCF Ratio | -0.00 | -0.01 | -0.02 | -0.01 | -0.00 | -4.91 | -5.83 | -0.00 | -0.00 | -8.16 | -10.93 | -0.01 | -0.01 | -0.01 | -0.05 | -0.01 | -0.01 |
P/OCF Ratio | -0.00 | -0.01 | -0.02 | -0.01 | -0.00 | -4.91 | -5.83 | -0.00 | -0.00 | -8.16 | -10.93 | -0.01 | -0.01 | -0.01 | -0.05 | -0.01 | -0.01 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.08 | 0.15 | -0.15 | -0.27 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 0.16 | 0.15 | 0.29 | 0.58 | 0.44 | 0.95 | 0.95 | 1.53 | n/a | 1.15 | 1.15 | 3.73 | 3.52 | 1.91 | 4.38 | 1.48 | 2.00 |
Current Ratio | 0.16 | 0.15 | 0.29 | 0.58 | 0.44 | 0.95 | 0.95 | 1.53 | n/a | 1.15 | 1.15 | 3.73 | 3.52 | 1.91 | 4.38 | 1.48 | 2.00 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -64.09 | -42.56 | -42.42 | -146.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.17 | -0.17 | 0.43 | 2.04 | 1.57 | 15.30 | 15.30 | -1.08 | 0.56 | -1.92 | -1.92 | -0.67 | -0.37 | -1.01 | -0.13 | -2.76 | -1.48 |
Return on Assets | -0.07 | -0.07 | -1.06 | -1.49 | -2.01 | -0.8 | -0.8 | -0.37 | n/a | -0.25 | -0.25 | -0.49 | -0.26 | -0.48 | -0.1 | -0.91 | -0.74 |
Return on Invested Capital | -0.11 | -0.16 | 0.51 | 2.76 | 1.69 | 16.59 | 16.59 | -3.31 | n/a | -3.36 | -3.36 | -0.68 | -0.37 | -1.03 | -0.13 | -2.74 | -1.41 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |